IP Library › Granted Patent US 9,199,897
Granted Patent B2
US 9,199,897 · App. 13/696,591 · Granted Dec 1, 2015

Methods for preparing squalene

Inventor: Maninder Hora (Pleasanton, CA)
Assignee: NOVARTIS AG
C07C7/04A61K39/39A61K47/06A61K9/107A61K2039/55566
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 9,199,897
App. No.
13/696,591
Granted
Dec 1, 2015
Kind
B2
Abstract

An improved method for preparing squalene from a squalene-containing composition, said method comprising the steps of (a) a purification distillation carried out at a temperature T 1 ; (b) a denaturing distillation carried out at a temperature T 2 ; wherein steps (a) and (b) may be performed in either order; T 1 and T 2 are sufficient to cause squalene to boil; T 2 >T 1 ; and T 2 >200° C.

Claims (17)

1. A method for manufacturing squalene suitable for pharmaceutical use in a vaccine which comprises subjecting fish oil comprising squalene to:

(i) a purification distillation carried out at near vacuum; and

(ii) a denaturing distillation carried out at a temperature greater than or equal to 210° C. at a pressure of 0.8 to 5.0 mmHg, wherein the temperature in the denaturing distillation exceeds the temperature in the purification distillation; and

wherein the conditions for both the purification distillation and the denaturing distillation are sufficient to cause the squalene to boil; and

wherein the denaturing distillation denatures and/or removes potential contaminant proteins and viruses, thereby rendering the squalene safer for human use as compared with non-denatured squalene.

2. The method of claim 1 , wherein the purification distillation occurs at a temperature of less than 140° C.

3. The method of claim 1 , wherein the fish oil comprises one or more contaminant proteins.

4. The method of claim 3 , wherein the contaminant protein comprises parvalbumin.

5. The method of claim 1 , wherein the purification distillation is carried out at a temperature of from 70 to 100° C.

6. The method of claim 1 , wherein the purification distillation is carried out at a pressure of from 0.5 μm Hg to 5 μm Hg.

7. The method of claim 1 , wherein the purification distillation is carried out prior to the denaturing distillation.

8. The method of claim 1 , which further comprises a step of subjecting the fish oil to saponification prior to conducting the purification distillation and denaturing distillation steps.

9. The method of claim 1 , which further comprises a step of subjecting the fish oil to saponification before conducting the denaturing distillation step.

10. The method of claim 8 , wherein saponification comprises the addition of NaOH or KOH to the fish oil.

11. The method of claim 9 , wherein saponification comprises the addition of NaOH or KOH to the fish oil.

12. The method of claim 1 , wherein the purification distillation results in a composition comprising 99% squalene or more.

13. The method of claim 1 , wherein the fish oil is shark liver oil.

Assignments (3)
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Dec 19, 2024
From: NOVARTIS AG
To: SEQIRUS UK LIMITED
Reel/Frame 069642/0293 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2013
From: HORA, MANINDER
To: NOVARTIS VACCINES AND DIAGNOSTICS, INC.
Reel/Frame 031108/0888 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Aug 29, 2013
From: NOVARTIS VACCINES & DIAGNOSTICS, INC.
To: NOVARTIS AG
Reel/Frame 031109/0003 →
Continuity (2)
Provisional Application 61395448 · May 12, 2010
Related Publication 20130209510A1 · Aug 15, 2013